Anti-vaccine advocates have been deploying a new tactic: pushing for unvaccinated individuals to become a protected group under constitutional and statutory law. Expert Valerie Gutmann Koch explores why this could threaten public health.
From urban revitalization in Houston’s Third Ward to displacement due to climate change in East Africa, students are engaging with a broad range of policy topics at the Baker Institute this fall through internships and the Baker Institute Student Forum.
Vaccination policies are a cornerstone of public health, but anti-vaccine activists have been adamantly pushing for legislation that would weaken and dismantle the public health infrastructure, the authors write. In this issue brief, they examine vaccine policy challenges leading up to and during the COVID-19 pandemic, as well as the future of vaccine legislation in Texas and the United States.
The authors identify key themes that emerged from anti-vaccine testimonies during the 2021 Texas legislative session and consider the implications of these discussions as the next legislative session draws near.
As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.
As the European Union develops a carbon border tax and the United States considers its own, this report argues for the need to track cross-border carbon trade comprehensively — including trade in fossil fuels.
Stem cells have two unique properties that make them an appealing therapeutic tool for regenerative medicine: they can grow indefinitely and can differentiate into a wide variety of cell types, including those that form blood, bones, lungs, skin, and the brain.
As the reality of protracted drought pervades the border region, the need for greater cooperation between the United States and Mexico on transboundary groundwater management is becoming more urgent, writes nonresident scholar Stephen Mumme.
With the recent enactment of the CHIPS and Science Act, the conversation about industrial policy has started up again. Are state-directed economic policies back, and will such initiatives work?